nafagrel has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Funakoshi, M; Horiguchi, S; Karibe, A; Katoh, H; Keitoku, M; Kohzuki, M; Nose, M; Okayama, H; Satoh, S; Shirato, K; Suzuki, S; Takeuchi, M; Watanabe, J | 1 |
1 other study(ies) available for nafagrel and n-formylmethionine leucyl-phenylalanine
| Article | Year |
|---|---|
FMLP actions and its binding sites in isolated human coronary arteries.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Coronary Vessels; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Imidazoles; Indomethacin; Intramolecular Oxidoreductases; Isomerases; Isometric Contraction; Macrophages; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Prostaglandins; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; RNA, Messenger; Tetrahydronaphthalenes; Thromboxane A2; Thromboxane-A Synthase | 1997 |